Down Syndrome: From Understanding the Neurobiology to Therapy, Volume 197

1st Edition

Serial Volume Editors: Mara Dierssen Rafael de la Torre Fornell
Hardcover ISBN: 9780444542991
eBook ISBN: 9780444543004
Imprint: Elsevier
Published Date: 1st May 2012
Page Count: 272
280.00 + applicable tax
170.00 + applicable tax
215.00 + applicable tax
279.04 + applicable tax
Unavailable
Compatible Not compatible
VitalSource PC, Mac, iPhone & iPad Amazon Kindle eReader
ePub & PDF Apple & PC desktop. Mobile devices (Apple & Android) Amazon Kindle eReader
Mobi Amazon Kindle eReader Anything else

Institutional Access


Table of Contents

  1. Therapeutic approaches in the improvement of cognitive performance in Down syndrome: past, present and future
  2. Rafael de la Torre and Mara Dierssen

  3. Genomic determinants in the phenotypic variability of Down syndrome
  4. Audrey Letourneau and Stylianos E. Antonarakis

  5. Intellectual disabilities, neuronal post-transcriptional RNA-metabolism and RNA-binding proteins: three actors for a complex scenario
  6. Barbara Bardoni, Sabiha Abekhoukh, Samantha Zongaro and Mireille Melko

  7. Aberrant epigenetic landscape in mental retardation
  8. Sanchez-Mut JV, Huertas D. and Esteller M.

  9. Pathways to cognitive deficits in Down syndrome
  10. Xiaolu Sturgeon, Thanh Le, Md. Mahiuddin Ahmed and Katheleen J. Gardiner

  11. Neurological Phenotypes for Down Syndrome across the Lifespan
  12. Ira T. Lott, MD

  13. Human and mouse model cognitive phenotypes in Down syndrome: Implications for assessment
  14. Jamie O. Edgin, Gina M. Mason, Goffredina Spanò, Andrea Fernández and Lynn Nadel

  15. Perturbation of dendritic protrusions in intellectual disability
  16. Josien Levenga and Rob Willemsen

  17. The in vivo Down syndrome genomic library in mouse
  18. Yann Herault, Arnaud Duchon, Emilie Velot, Damien Maréchal and Véronique Brault

  19. Discoveries in Down Syndrome: Moving Basic Science to Clinical Care
  20. A.M. Kleschevnikov, P.V. Belichenko, A. Salehi and C. Wu

  21. A Sonic hedgehog (Shh) response deficit in trisomic cells may be a common denominator for multiple features of Down syndrome
  22. Duane G. Currier, Renita C. Polk and Roger H. Reeves

  23. Gene therapy for Down syndrome

    Cristina Fillat and Xavier Altafaj

Description

Down syndrome (DS) is the most common example of neurogenetic aneuploid disorder leading to mental retardation. In most cases, DS results from an extra copy of chromosome 21 (HSA21) producing deregulated gene expression in brain that gives raise to subnormal intellectual functioning. The topic of this volume is of broad interest for the neuroscience community, because it tackles the concept of neurogenomics, that is, how the genome as a whole contributes to a neurodevelopmental cognitive disorders, such as DS, and thus to the development, structure and function of the nervous system.

This volume of Progress in Brain Research discusses comparative genomics, gene expression atlases of the brain, network genetics, engineered mouse models and applications to human and mouse behavioral and cognitive phenotypes. It brings together scientists of diverse backgrounds, by facilitating the integration of research directed at different levels of biological organization, and by highlighting translational research and the application of the existing scientific knowledge to develop improved DS treatments and cures.

Key Features

  • Leading authors review the state-of-the-art in their field of investigation and provide their views and perspectives for future research
  • Chapters are extensively referenced to provide readers with a comprehensive list of resources on the topics covered
  • All chapters include comprehensive background information and are written in a clear form that is also accessible to the non-specialist

Readership

Neuroscientists, psychologists, neurologists


Details

No. of pages:
272
Language:
English
Copyright:
© Elsevier 2012
Published:
Imprint:
Elsevier
eBook ISBN:
9780444543004
Hardcover ISBN:
9780444542991

Reviews

Down syndrome (DS) is the most common example of neurogenetic aneuploid disorder leading to mental retardation. In most cases, DS results from an extra copy of chromosome 21 (HSA21) producing deregulated gene expression in brain that gives raise to subnormal intellectual functioning. The topic of this volume is of broad interest for the neuroscience community, because it tackles the concept of neurogenomics, that is, how the genome as a whole contributes to a neurodevelopmental cognitive disorders, such as DS, and thus to the development, structure and function of the nervous system.

This volume of Progress in Brain Research discusses comparative genomics, gene expression atlases of the brain, network genetics, engineered mouse models and applications to human and mouse behavioral and cognitive phenotypes. It brings together scientists of diverse backgrounds, by facilitating the integration of research directed at different levels of biological organization, and by highlighting translational research and the application of the existing scientific knowledge to develop improved DS treatments and cures.


About the Serial Volume Editors

Mara Dierssen Serial Volume Editor

Rafael de la Torre Fornell Serial Volume Editor